Skip to main content
Peter Butler, MD, Endocrinology, Los Angeles, CA

PeterCawoodButlerMD

Endocrinology Los Angeles, CA

Diabetes, Lipid Metabolism

Professor, Medicine, UCLA School of Medicine

Are you Dr. Butler?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 47 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    200 Medical Plaza
    365
    Los Angeles, CA 90095
    Phone+1 310-825-7922

Summary

  • Dr. Peter Butler, MD is an endocrinologist in Los Angeles, California. He is currently licensed to practice medicine in California, Minnesota, and North Carolina. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1993
  • Freeman Health System
    Freeman Health System1982 - 1984
  • Birmingham University Medical School
    Birmingham University Medical SchoolClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2025
  • MN State Medical License
    MN State Medical License 1993 - 2002
  • NC State Medical License
    NC State Medical License 1990 - 1992

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • ® Announces Latest Institute for Value-Based Medicine® Meeting
    ® Announces Latest Institute for Value-Based Medicine® MeetingApril 2nd, 2019
  • Type 2 Diabetes Drug May Cause Cancer
    Type 2 Diabetes Drug May Cause CancerJanuary 29th, 2016

Grant Support

  • Capacity And Mechanisms Of Beta Cell Regeneration In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
  • Role Of IAPP In Islet Dysfunction In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2012
  • Role Of Pulsatile Insulin SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
  • Role Of Pulsatile Insulin Secretion.National Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
  • Role Of Pulsatile Insulin Secretion.National Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
  • Role Of IAPP In Islet Dysfunction In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
  • Restoration Of First Phase Insulin Secretion On Pulsatile Secretion In NIDDMNational Center For Research Resources1996–1997
  • Pulsatile Insulin Secretion By Hepatic Transplanted IsletsNational Center For Research Resources1995
  • Pulsatile Insulin Secretion On Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
  • Role Of Pulsatile Insulin Secretion On Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
  • Isotopes Of Glucose, Leucine, And Palmitate As Irreversible Tracers Of GlucoseNational Center For Research Resources1992